Results

Total Results: 1,569 records

Showing results for "discussion".

341. Table 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-end-of-life-indicators-symposium_research.pdf
     April 01, 2010 - ................................................................................................5 Discussion … The authors summarized the notes of each group’s discussion and presentation after the symposium and … Key aspects include a discussion of the prognosis or expected course of the illness, patient priorities … Discussion Examining the priority issues of all the domains exposed a number of cross-cutting themes … the benefits and burdens) and include a discussion about goals of care during the consent process

342. #06 Developmental Delays ADHD, and Autism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - ES-2 Discussion ................................................................................... … separately), and then topics in the same class of a device, drug, or biologic are aggregated for discussion … is that this intervention is in the moderate high-impact-potential range. 4 Results and Discussion … health systems backgrounds, provided comments on this topic.33-38 We have organized the following discussion … Executive Summary Background Methods Results Discussion Off-Label Intranasal Oxytocin for Treatment

343. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1406.pdf
     February 01, 2015 - ES-2 Discussion ................................................................................... … separately), and then topics in the same class of a device, drug, or biologic are aggregated for discussion … intranasal insulin for treatment of Alzheimer’s disease Lower end of the high-impact-potential range Discussion … Results and Discussion of Comments Six experts, with clinical, research, and health devices backgrounds … , offered perspectives on this intervention.24-29 We have organized the following discussion of expert

344. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/dementia_horizon-scan-high_impact-1306-revised.pdf
     July 09, 2013 - ES-2 Discussion ................................................................................... … Results and Discussion of Comments One group of experts (6 people) with clinical, research, and health … We have organized the following discussion of expert comments according to the parameters on which … Results and Discussion of Comments Six experts, with clinical, research, and health systems backgrounds … , offered perspectives on this intervention.52-57 We have organized the following discussion of expert

345. Integrating Bodies of Evidence: Existing Systematic Reviews and Primary Studies (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/integrating-evidence_methods.pdf
     February 01, 2015 - Ground Rules for Discussion Session The discussions will be tape recorded, transcribed, and analyzed … You may refrain from answering any questions and are welcome to leave the discussion at any time. … In this discussion, we will present you with one or more specific examples of reviews using existing … The goal of this discussion is to examine these examples within each scenario and understand how you … May discuss existing reviews that are not used in the discussion section B-2 Integrating Bodies

346. Disposition of Comments Report for Technical Brief 14 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-survivor-care-transition_disposition-comments.pdf
     March 18, 2014 - This has been added to the Discussion section. … The discussion of guidelines is interesting and critical. … TEP Reviewer 6 Discussion and Conclusion 1. … Isn’t discussion of that, or discussion of the cost of various models, some more, some less or the … Added to Discussion Points from Reviewers section.

347. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/05_depression_potential_high_impact_2012-12-10.pdf
     January 01, 2012 - ES-2 Discussion ................................................................................... … separately), and then topics in the same class of a device, drug, or biologic are aggregated for discussion … Results and Discussion of Comments Six experts, with clinical, research and health systems backgrounds … Results and Discussion of Comments Six experts, with clinical, research, and health systems backgrounds … Results and Discussion of Comments Seven experts, with clinical, research, and health systems backgrounds

348. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/05_depression_potential_high_impact_june_2012.pdf
     January 01, 2012 - ES-2 Discussion ................................................................................... … separately), and then topics in the same class of a device, drug, or biologic are aggregated for discussion … For purposes of this report, we aggregated related topics for summary and discussion (e.g., individual … Results and Discussion of Comments Six experts, with clinical, research and health systems backgrounds … Results and Discussion of Comments Six experts, with clinical, research, and health systems backgrounds

349. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_june_2012.pdf
     January 01, 2012 - ES-2 Discussion ................................................................................... … Tesofensine for treatment of obesity No high-impact potential at this time Discussion Based on current … Results and Discussion of Comments Six experts, with clinical, research, health systems, and health … Results and Discussion of Comments Six experts, with clinical, research, health systems, and health … id=32 Executive Summary Background Methods Results Discussion Phentermine/Topiramate (Qnexa) for

350. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/04_dementia_potential_high_impact_2012-12-10.pdf
     January 01, 2012 - ES-2 Discussion ................................................................................... … separately), and then topics in the same class of a device, drug, or biologic are aggregated for discussion … For the Potential High-Impact Interventions Report, we aggregated related topics for summary and discussion … Results and Discussion of Comments Six experts, with clinical, research, and health systems backgrounds … Results and Discussion of Comments Six experts, with clinical, research, and health systems backgrounds

351. Using Deliberative Methods to Engage Patients, Consumers, and the Public (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/deliberative-methods_presentation-2011.pdf
     January 01, 2011 - Examples from the literature IOM committee report on essential benefits Interactive exercise Discussion … methods Opinion polling Focus groups Deliberative methods Education Convening of groups Discussion

352. Naik (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/naik.pdf
     January 01, 2009 - made goals concordant and implicit o Many care goals are similar across patients  Reduces need for discussion … www.effectivehealthcare.ahrq.gov/index.cfm) http://www.effectivehealthcare.ahrq.gov/index.cfm) � Slide 23: Questions  and Discussion

353. new disposition of comments insulin analogues -- jda revs.xls (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/insulin-analogues-disposition-081229.pdf
     September 01, 2008 - We have mentioned this in the discussion section. … We have pointed out these two issues in the Discussion section of the report. … We have pointed out this limitation of the studies in the Discussion section. … We have referenced ACCORD trial in the Discussion section. … We have added a sentence of this effect in the conclusion subsection of the discussion section.

354. Disposition of Comments for Technical Brief 27 Patient Safety (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ambulatory-safety_disposition-comments.pdf
     October 19, 2016 - The Kis had a far-ranging discussion on medication safety, but it was not a comprehensive discussion … The entire workflow of ambulatory care is being reshaped by EMRs and HIT; we need more discussion of … The KI discussion was more focused on unintended consequences than advantages, but we have added to … I don't see adequate discussion of these areas. … The team arrived at final themes through discussion and consensus.

355. Disposition of Comments Technical Brief 30 Assessment Tools for Palliative Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/palliative-care-tools-disposition.pdf
     May 04, 2017 - We have added to the discussion, “Other organizations may use the survey of tools in this report to … What Based on discussion with the key informants, we used the definition from “Dying in America”. … For example, it is unclear if patients themselves were informants (see later discussion on "patient … Though I can’t recall whether it was mentioned in Key Informant discussion it now seems that other … Kim Kuebler) Discussion Structure of care from the National Consensus Model is missing important,

356. Disposition of Comments Technical Brief 30 Assessment Tools for Palliative Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/palliative-care-tools-disposition.pdf
     May 04, 2017 - We have added to the discussion, “Other organizations may use the survey of tools in this report to … What Based on discussion with the key informants, we used the definition from “Dying in America”. … For example, it is unclear if patients themselves were informants (see later discussion on "patient … Though I can’t recall whether it was mentioned in Key Informant discussion it now seems that other … Kim Kuebler) Discussion Structure of care from the National Consensus Model is missing important,

357. Disposition of Comments for CER 195 Management of Uterine Fibroids (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-195-disposition-comments-uterine-fibroids.pdf
     December 14, 2017 - Peer reviewer #1 Discussion/ Conclusion 1. … I'd like to see more nuanced discussion and analysis of this. … TEP Reviewer #2 Discussion/ Conclusion Not enough time to get longer term info with UPA. … TEP Reviewer#4 Discussion/ Conclusion Next intervention may be affected by insurance type. … Noted this in Analysis Methods in the discussion.

358. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/12_pregnancy_potential_high_impact_2012-12-11.pdf
     January 01, 2012 - ES-2 Discussion ................................................................................... … separately), and then topics in the same class of a device, drug, or biologic are aggregated for discussion … Ulipristal acetate (CDB-2914) for uterine fibroids No high-impact potential at this time Discussion … Results and Discussion of Comments Seven experts, with clinical, research, health systems, and health … Executive Summary Background Methods Results Discussion Donor Human Milk Program for Very-Low-Birthweight

359. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - ES 2 Discussion ................................................................................... … separately), and then topics in the same class of a device, drug, or biologic are aggregated for discussion … pregnancy No high-impact potential at this time; topic being archived after 4 years of tracking Discussion

360. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - ES-2 Discussion ................................................................................... … separately), and then topics in the same class of a device, drug, or biologic are aggregated for discussion … Results and Discussion of Comments Six experts, with clinical, research, and health systems backgrounds … , offered comments on this intervention.14-19 We have organized the following discussion of expert … Executive Summary Background Methods Results Discussion Prior Potential High Impact Topic Archived